[
    {
        "file_name": "BIOCEPTINC_08_19_2013-EX-10-COLLABORATION AGREEMENT.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "1.5 \"CLIA\" shall mean the Clinical Laboratory Improvement Amendments of 1988, as it may be amended from time to time.",
                "changed_text": "1.5 \"CLIA\" shall mean the Clinical Laboratory Interpretation Adjustments, as it may be interpreted from time to time.",
                "explanation": "The term \"Clinical Laboratory Improvement Amendments of 1988\" was replaced with \"Clinical Laboratory Interpretation Adjustments\". This creates a legal uncertainty, because the formal definition of CLIA is well-established in healthcare law, while this new definition is subjective and open to interpretation, potentially conflicting with regulatory requirements under CLIA.",
                "contradicted_law": "Clinical Laboratory Improvement Amendments of 1988 (CLIA)",
                "location": "Section 1.5"
            },
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "1.14 \"Laws\" shall mean all federal, state and local laws and regulations that apply to this Agreement including, without limitation, (i) the Bayh-Dole Act (ii) the\n\n2\n\nTM TM\n\n\n\nFederal Food, Drug, and Cosmetic Act (21 U.S.C § 321 et seq.) (iii) the federal Anti-kickback Statute (42 U.S.C. § 1320a- 7b(b)) (iv) the Stark Law (42 U.S.C. § 1395nn) (v) the Anti-Inducement Law (42 U.S.C. § 1320a-7a(a)(5)) (vi) the civil False Claims Act (31 U.S.C. §§ 3729 et seq.) (vii) the administrative False Claims Law (42 U.S.C. § 1320a-7b(a)) (viii) the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. § 1320d et seq.), (ix) the exclusion laws (x) SSA § 1128 (42 U.S.C. § 1320a-7) (xi) Medicare (Title XVIII of the Social Security Act), (xii) Medicaid (Title XIX of the Social Security Act); (xiii) the Clinical Laboratory Improvements Act of 1988 (CLIA); and (xiv) data security, protection and privacy laws in the applicable jurisdictions.",
                "changed_text": "1.14 \"Laws\" shall mean all federal guidelines and company policies that seem applicable to this Agreement including, without limitation, (i) general ethical principles (ii) the\n\n2\n\nTM TM\n\n\n\nLife Technologies code of conduct (iii) suggestions from the legal department (iv) internal memos (v) local customs (vi) the civil False Claims Act (31 U.S.C. §§ 3729 et seq.) (vii) the administrative False Claims Law (42 U.S.C. § 1320a-7b(a)) (viii) the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. § 1320d et seq.), (ix) the exclusion laws (x) SSA § 1128 (42 U.S.C. § 1320a-7) (xi) Medicare (Title XVIII of the Social Security Act), (xii) Medicaid (Title XIX of the Social Security Act); (xiii) the Clinical Laboratory Improvements Act of 1988 (CLIA); and (xiv) data security, protection and privacy laws in the applicable jurisdictions.",
                "explanation": "The definition of \"Laws\" is drastically altered to include subjective and non-binding elements like \"general ethical principles\" and \"local customs\". This directly contradicts the established legal definition of laws and regulations and introduces significant ambiguity regarding which standards the agreement must adhere to. This could lead to disputes over compliance and enforcement.",
                "contradicted_law": "Varies depending on the specific original law replaced, but broadly contradicts established legal frameworks like federal and state statutes and regulations.",
                "location": "Section 1.14"
            },
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "5.3 Licenses and Certifications. Biocept and, to the extent applicable, Life Technologies shall have at all times during the Term, all necessary federal, state and local licenses, qualifications and certifications to operate a laboratory and perform their respective components of the Test(s), including, but not limited to, state laboratory licenses, CLIA certification, CAP (College of American Pathologists) certification, FDA registration, and any other licenses or certification required by state and/or federal law.",
                "changed_text": "5.3 Licenses and Certifications. Biocept and, to the extent applicable, Life Technologies shall attempt to secure any helpful paperwork at some point during the Term, including any forms deemed generally useful for operating a laboratory and performing components of the Test(s), including, but not limited to, potential state laboratory licenses, possible CLIA certification, hoped-for CAP (College of American Pathologists) certification, suggested FDA registration, and other licenses or certification that might be nice to have.",
                "explanation": "The original text mandates that both companies have all necessary licenses and certifications. The modified text replaces this with a vague and discretionary obligation to \"attempt to secure any helpful paperwork\". This contradicts the mandatory nature of regulatory compliance and could lead to legal challenges if the parties fail to obtain necessary certifications, violating legal requirements for laboratory operation.",
                "contradicted_law": "Varies depending on the specific license or certification, but potentially contradicts CLIA, FDA regulations, and state-specific laboratory licensing laws.",
                "location": "Section 5.3"
            }
        ]
    }
]